Serum N -glycans outperform CA19-9 in diagnosis of extrahepatic cholangiocarcinoma
نویسندگان
چکیده
منابع مشابه
Serum CEA, CA125, CA19-9, and CA724 levels for the diagnosis and staging of cholangiocarcinoma
Background: Aims serum markers provide a non-invasive, cheap and effective diagnostic and prognostic tool for cholangiocarcinoma. In this study, we aimed to evaluate serum levels of CEA, CA125, CA19-9 and CA724 for the diagnosis and staging of cholangiocarcinoma. Materials and methods: Serum levels of CA125, CA19-9, CA724 and CEA were measured preoperatively, postoperatively and during follow-u...
متن کاملDiagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis
BACKGROUND Cholangiocarcinoma (CCA) is a relatively rare cancer worldwide; however, its incidence is extremely high in Asia. Numerous studies reported that serum carbohydrate antigen 19-9 (CA19-9) plays a role in the diagnosis of CCA patients. However, published data are inconclusive. The aim of this meta-analysis was to provide a systematic review of the diagnostic performance of CA19-9 for CC...
متن کاملPreoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
To investigate the appropriate cutoff point of CA19-9 for prognosis and other potential prognostic factors that may affect survival of patients with hilar cholangiocarcinoma (HC) after radical surgery. 168 patients who had undergone radical surgery for hilar cholangiocarcinoma and resultant macroscopic curative resection (R0 and R1) were discreetly selected for analyses. Categorized versions we...
متن کاملSerum CA19-9, CEA, CA125 and CA242 for Diagnosis and Prognosis in Pancreatic Cancer Cases
Pancreatic cancer is one of the common malignant tumors in digestive system, with poor prognosis (Lin et al., 2015). 90% of pancreatic cancer is ductal adenocarcinoma deriving from ductal epithelial cells and only a few deriving from acinous cells. Pancreatic cancer is insidious malignancy of high mortality in clinic, with the overall 5-year survival rate being only 0.4%~4.0% (Jemal et al., 200...
متن کاملSerum CA19-9 in patients with solid pancreatic mass
AIM This study evaluated the results and efficacy of serum CA 19-9 in determining the nature of a pancreatic solid mass in patients referred for investigation of possible malignancy. BACKGROUND A wide variety of tumor markers have been proposed for pancreatic cancer but currently the only one with any practical usefulness for diagnosis, prognosis, and monitoring of treatment is "CA 19-9". P...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ELECTROPHORESIS
سال: 2017
ISSN: 0173-0835
DOI: 10.1002/elps.201700084